Earnings Feed
Start Free
OSIRIS THERAPEUTICS, INC.·4

Mar 27, 2:27 PM ET

Debrabandere Lode 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 27, 2012

Insider Transaction Report

Form 4
Period: 2012-03-23
OSIRIS THERAPEUTICS, INC.OSIR
Debrabandere Lode
Vice President
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2012-03-23$5.08/sh+12,498$63,490→ 230,000 total
    Exercise: $5.08From: 2013-03-23Exp: 2022-03-22→ Common Stock (12,498 underlying)
  • Award

    Incentive Stock Option (right to buy)

    2012-03-23$5.08/sh+12,502$63,510→ 217,502 total
    Exercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common Stock (12,502 underlying)
Footnotes (1)
  • [F1]Options to purchase 25,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 23, 2013, 2014, 2015 and 2016, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -